Glimepiride Tablets
Supplier Details
Beijing Beilu Pharmaceutical Co., Ltd
Free Member (2021)
[ Miyun, BE,China ]
Business Type: Manufacturer
Supplier has 5 products
Quick Details
Packaging and Delivery
Product Description
Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets Dibei, as the first hypoglycemic product of the company, was first listed in China and belongs to the second class of national new drugs.
Product name: Glimepiride Tablets
Specifications: glimepiride 1 mg×30 tablets? glimepiride 2mg dosage×15 tablets?glimepiride 2mg×30 tablets
Characteristics: White tablet
Indications :
As one of the oral antidiabetic drugs produced by Beilu Pharma, our glimepiride tablets are only suitable for type 2 diabetes that cannot fully control blood sugar through diet control, exercise therapy and weight loss.
Glimepiride tablets are not suitable for type 1 diabetes for example, the treatment of diabetic patients with a history of ketoacidosis, diabetic ketoacidosis or Treatment of pre-diabetic coma or coma.
Usage and Dosage: Please refer to the package insert
Adverse reactions, Contraindications, Precautions: Please refer to the package insert.
Storage: Shade, seal, and keep in a dry place.
Packaging: Aluminum plastic packaging, 15 pills/plate, 1 plate/box; 15 pills/plate, 2 plates/box.
Shelf life: 24 months
Advantages of Glimepiride Tablets
Double effect directly hit the hypoglycemic core
Double effect: Glimepiride tablets can promote insulin secretion and improve insulin resistance. At the same time, it can improve the two major pathophysiological abnormalities of insulin secretion and insulin resistance in patients with type 2 diabetes.
Efficiently reduce postprandial blood glucose, fasting blood glucose and glycosylated haemoglobin
Glimepiride tablets monotherapy can comprehensively reduce FPG PPG and HbA1c in newly diagnosed T2DM patients
Combination therapy, such as combined metformin, acarbose, etc., has a more significant overall hypoglycemic effect
Less hypoglycemia, less weight impact, high safety
Short-term treatment, the risk of glimepiride hypoglycemia is only 1/3 of that of Glibenclamide
Long-term treatment, the risk of glimepiride hypoglycemia is only 1/7of that of Glibenclamide
Glimepiride has a small impact on the weight of T2DM patients
Once a day to improve patient compliance
If the patient's compliance is poor, Glimepiride tablets should be selected, once a day.
Beijing Beilu Pharmaceuticals Company Limited is a professional anti-anxiety drugs manufacturer, we provide glimepiride 2mg dosage, glimepiride tablets and etc. Want to know glimepiride 2mg tablets price Contact us now.
Basic Information
About Us
Founded in 1992, Beilu is a high-tech innovation company with core competence in diagnostic imaging field in China. It has around 650 employees with 0.82 Bn? revenue in 2019. We have the most complete Contrast media categories and are the leading manufacture in Contrast media field in China. It is one of the 1st batch of listed enterprises in GEM in China. Beilu s main products are Contrast media, psychoneurosis traditional Chinese medicine and endocrinology drugs that to benefit people and improve their quality of life. Contrast media are widely used to improve pictures of the inside of the body produced by X-rays, computed tomography CT, magnetic resonance MR imaging etc.. Psychoneurosis traditional Chinese medicine are the original products with Chinese patent to contribution to improve the physical and mental status. In 2020, Beilu Pharma completed the acquisition of Hichi Pharm to realize the layout of industrial chain integration.
